Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...
HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO) reported fourth-quarter results that fell short of analyst expectations, sending shares down 4% in after-hours trading Thursday. The life ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company ...
Bio-Rad’s assays use real-time polymerase chain reaction technology to amplify and detect specific DNA sequences of target ...
The firm's CT/NG Positive Run Control and STI Negative Run Control will be the first products CE-marked under IVDR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback